We investigated the clinical significance of a recently identified association between insulin-like growth factor binding protein 3 (IGFBP-3), that plays a key role in breast cancer progression, and glucose-regulated protein 78 (GRP78). Here, IGFBP3 is linked to breast carcinoma.